步长制药 (603858.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(步长制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 3,025,545,041.213,442,726,995.813,514,950,369.963,646,532,439.984,206,623,322.913,897,598,808.593,200,498,122.98
 营业收入(元) 3,025,545,041.213,442,726,995.813,514,950,369.963,646,532,439.984,206,623,322.913,897,598,808.593,200,498,122.98
二、营业总成本(元) 2,803,308,188.053,173,967,934.633,106,734,181.093,228,653,490.973,667,641,442.013,474,158,350.092,878,436,507.43
 营业成本(元) 949,989,675.051,116,804,372.801,061,920,884.20836,994,278.011,092,369,005.601,420,808,808.37882,338,333.88
 研发费用(元) 50,706,713.4363,465,027.9436,838,151.8548,412,651.96136,154,915.8353,488,088.6346,066,527.20
 营业税金及附加(元) 49,677,420.3854,624,944.8757,238,808.0963,287,777.4360,208,304.8456,829,669.2951,741,850.84
 销售费用(元) 1,461,334,595.751,666,971,337.301,711,896,547.362,006,636,729.142,146,540,034.071,693,222,766.991,637,806,435.14
 管理费用(元) 263,162,078.68250,725,000.89223,839,862.29251,211,216.20206,268,886.71216,940,504.49228,035,622.03
 财务费用(元) 28,437,704.7621,377,250.8314,999,927.3022,110,838.2326,100,294.9632,868,512.3232,447,738.34
  其中:利息费用(元) 32,318,390.6226,273,095.3126,274,295.8129,431,789.8632,821,891.7630,302,152.3142,544,108.37
  其中:利息收入(元) 4,658,342.505,293,079.3312,154,881.734,719,860.816,787,768.27156,807.928,209,238.07
 资产减值损失(元) 7,715,795.00-10,742,779.091,285,592.05-3,167,144,120.36-140,315.504,666,092.46
 信用减值损失(元) 5,979,888.286,965,478.95518,836.11-15,114,557.61-7,033,286.35-5,720,486.1410,737,083.80
三、其他经营收益
 加:公允价值变动收益(元) -2,356,116.15------
 加:投资收益(元) -1,524,773.9312,638,336.306,735,002.10-9,095,112.662,232,575.4712,541,825.49-2,943,792.56
  其中:对联营企业和合营企业的投资收益(元) -3,923,925.115,420,398.902,751,731.97-5,172,802.68-1,186,470.939,839,344.94-4,595,242.08
 资产处置收益(元) 620,338.1824,230.44-8,061.63778,317.44223.0122,696.18-28,133.22
 其他收益(元) 10,531,737.3079,885,706.90101,936,895.00-153,017,961.3619,832,633.9633,969,963.48196,219,314.24
四、营业利润(元) 243,203,721.84358,708,092.76518,684,452.50-2,925,714,485.54554,014,026.99464,394,773.01530,712,180.27
 加:营业外收入(元) 1,303,596.53502,373.68762,628.292,422,918.50876,911.13-841,845.442,031,701.88
 减:营业外支出(元) 27,990,920.419,467,187.654,904,132.863,045,529.723,138,335.921,596,461.306,638,509.19
五、利润总额(元) 216,516,397.96349,743,278.79514,542,947.93-2,926,337,096.76551,752,602.20461,956,466.27526,105,372.96
 减:所得税费用(元) 68,863,830.02102,101,306.6878,603,903.9016,038,854.93111,298,483.8688,958,248.98115,298,755.99
六、净利润(元) 147,652,567.93247,641,972.12435,939,044.03-2,942,375,951.69440,454,118.34372,998,217.29410,806,616.97
(一)按经营持续性分类
  持续经营净利润(元) 147,652,567.93247,641,972.12435,939,044.03-2,942,375,951.69440,454,118.34372,998,217.29410,806,616.97
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 179,005,384.96290,869,216.17455,269,033.72-2,923,736,758.54448,482,241.98388,530,956.15429,845,317.90
  少数股东损益(元) -31,352,817.02-43,227,244.06-19,329,989.69-18,639,193.15-8,028,123.64-15,532,738.86-19,038,700.93
 扣除非经常性损益后的净利润(元) 191,424,924.01232,057,491.35376,959,406.85-2,807,095,168.97434,567,051.09364,141,404.95279,645,127.59
七、每股收益
 一、基本每股收益(元) 0.160.260.41-2.640.410.350.39
 二、稀释每股收益(元) 0.160.260.41-2.640.410.350.39
八、其他综合收益(元) 57,415.071,732,651.04-2,325,971.842,089,667.62-1,331,856.02-5,983,543.27-1,938,864.59
 归属于母公司股东的其他综合收益(元) 57,415.071,732,651.04-2,325,971.842,089,667.62-1,331,856.02-5,983,543.27-1,938,864.59
九、综合收益总额(元) 147,709,983.00249,374,623.16433,613,072.19-2,940,286,284.07439,122,262.32367,014,674.02408,867,752.38
 归属于母公司所有者的综合收益总额(元) 179,062,800.03292,601,867.21452,943,061.88-2,921,647,090.92447,150,385.96382,547,412.88427,906,453.31
 归属于少数股东的综合收益总额(元) -31,352,817.02-43,227,244.06-19,329,989.69-18,639,193.15-8,028,123.64-15,532,738.86-19,038,700.93
公告日期 2023-10-282023-08-262023-04-282023-04-282022-10-282022-08-262022-04-28
审计意见(境内) 标准无保留意见

前瞻产业研究院